Current Edition

A World Leader in Naturally Derived Products Discusses Commercial Success
Current Features

A World Leader in Naturally Derived Products Discusses Commercial Success and New Innovations

Mr. Darren Alkins CEO at SPL – Scientific Protein Laboratories, speaks with IBI about their continued development in their science and technical expertise to meet …

Continue Reading →
Supporting Mergers and Acquisitions in the Pharmaceutical_Biopharmaceutical Industry
Current Features

Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry

In recent years, we have seen pharmaceutical company megadeals that saw Takeda acquiring Shire for a total value of $81.7 billion, Bristol-Myers Squibb’s acquisition of …

Continue Reading →
Dealing with the Challenges of Post-translational Modifications
Current Features

Dealing with the Challenges of Post-translational Modifications (PTMs)

During the structural analysis of recombinant protein biopharmaceutical products, a significant challenge is posed by the issue of Post Translational Modifications (PTMs). This is a …

Continue Reading →
Solving Critical Data Challenges for Chemicallymodified
Current Features

Solving Critical Data Challenges for Chemicallymodified, Biologically-based Therapeutic Candidates

The drug discovery research industry is seeing a growing prevalence of chemically-modified, biologically-based therapeutic candidates. This trend creates urgent and novel challenges for data management …

Continue Reading →
Using Lentiviral Vectors to Advance the Development of Therapeutic Vaccines
Current Features

Using Lentiviral Vectors to Advance the Development of Therapeutic Vaccines

Traditionally, vaccination has been used as a preventative strategy, aimed at curbing the impact of a wide range of infectious diseases. Over the past three …

Continue Reading →